A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.
Identifieur interne : 004697 ( PubMed/Curation ); précédent : 004696; suivant : 004698A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.
Auteurs : G M Petzinger [États-Unis] ; S B BressmanSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 1997.
English descriptors
- KwdEn :
- Adult, Anti-Dyskinesia Agents (administration & dosage), Anti-Dyskinesia Agents (adverse effects), Depressive Disorder (drug therapy), Depressive Disorder (psychology), Dyskinesia, Drug-Induced (drug therapy), Dyskinesia, Drug-Induced (etiology), Female, Humans, Neuroleptic Malignant Syndrome (diagnosis), Neuroleptic Malignant Syndrome (etiology), Neurologic Examination (drug effects), Tetrabenazine (administration & dosage), Tetrabenazine (adverse effects), Thiothixene (administration & dosage), Thiothixene (adverse effects).
- MESH :
- chemical , administration & dosage : Anti-Dyskinesia Agents, Tetrabenazine, Thiothixene.
- chemical , adverse effects : Anti-Dyskinesia Agents, Tetrabenazine, Thiothixene.
- diagnosis : Neuroleptic Malignant Syndrome.
- drug effects : Neurologic Examination.
- drug therapy : Depressive Disorder, Dyskinesia, Drug-Induced.
- etiology : Dyskinesia, Drug-Induced, Neuroleptic Malignant Syndrome.
- psychology : Depressive Disorder.
- Adult, Female, Humans.
DOI: 10.1002/mds.870120219
PubMed: 9087987
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004697
Links to Exploration step
pubmed:9087987Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.</title><author><name sortKey="Petzinger, G M" sort="Petzinger, G M" uniqKey="Petzinger G" first="G M" last="Petzinger">G M Petzinger</name><affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Columbia-Presbyterian Medical Center, New York, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Columbia-Presbyterian Medical Center, New York, New York</wicri:regionArea></affiliation></author><author><name sortKey="Bressman, S B" sort="Bressman, S B" uniqKey="Bressman S" first="S B" last="Bressman">S B Bressman</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1997">1997</date><idno type="RBID">pubmed:9087987</idno><idno type="pmid">9087987</idno><idno type="doi">10.1002/mds.870120219</idno><idno type="wicri:Area/PubMed/Corpus">004697</idno><idno type="wicri:Area/PubMed/Curation">004697</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.</title><author><name sortKey="Petzinger, G M" sort="Petzinger, G M" uniqKey="Petzinger G" first="G M" last="Petzinger">G M Petzinger</name><affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Columbia-Presbyterian Medical Center, New York, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Columbia-Presbyterian Medical Center, New York, New York</wicri:regionArea></affiliation></author><author><name sortKey="Bressman, S B" sort="Bressman, S B" uniqKey="Bressman S" first="S B" last="Bressman">S B Bressman</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="ISSN">0885-3185</idno><imprint><date when="1997" type="published">1997</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Anti-Dyskinesia Agents (administration & dosage)</term><term>Anti-Dyskinesia Agents (adverse effects)</term><term>Depressive Disorder (drug therapy)</term><term>Depressive Disorder (psychology)</term><term>Dyskinesia, Drug-Induced (drug therapy)</term><term>Dyskinesia, Drug-Induced (etiology)</term><term>Female</term><term>Humans</term><term>Neuroleptic Malignant Syndrome (diagnosis)</term><term>Neuroleptic Malignant Syndrome (etiology)</term><term>Neurologic Examination (drug effects)</term><term>Tetrabenazine (administration & dosage)</term><term>Tetrabenazine (adverse effects)</term><term>Thiothixene (administration & dosage)</term><term>Thiothixene (adverse effects)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-Dyskinesia Agents</term><term>Tetrabenazine</term><term>Thiothixene</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anti-Dyskinesia Agents</term><term>Tetrabenazine</term><term>Thiothixene</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Neuroleptic Malignant Syndrome</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Neurologic Examination</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Depressive Disorder</term><term>Dyskinesia, Drug-Induced</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term><term>Neuroleptic Malignant Syndrome</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Depressive Disorder</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">9087987</PMID><DateCreated><Year>1997</Year><Month>07</Month><Day>17</Day></DateCreated><DateCompleted><Year>1997</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>1997</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov. Disord.</ISOAbbreviation></Journal><ArticleTitle>A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.</ArticleTitle><Pagination><MedlinePgn>246-8</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Petzinger</LastName><ForeName>G M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Columbia-Presbyterian Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bressman</LastName><ForeName>S B</ForeName><Initials>SB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>UNITED STATES</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018726">Anti-Dyskinesia Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>7318FJ13YJ</RegistryNumber><NameOfSubstance UI="D013888">Thiothixene</NameOfSubstance></Chemical><Chemical><RegistryNumber>Z9O08YRN8O</RegistryNumber><NameOfSubstance UI="D013747">Tetrabenazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D018726">Anti-Dyskinesia Agents</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D003866">Depressive Disorder</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName><QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D004409">Dyskinesia, Drug-Induced</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName><QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D009459">Neuroleptic Malignant Syndrome</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D009460">Neurologic Examination</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D013747">Tetrabenazine</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D013888">Thiothixene</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1997</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1997</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9087987</ArticleId><ArticleId IdType="doi">10.1002/mds.870120219</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004697 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 004697 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:9087987
|texte= A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:9087987" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |